Core Insights - The launch of D-allulose by COFCO Group marks a significant breakthrough in China's high-end functional sugar sector, filling a gap in the domestic market and supporting the health transformation of the food industry [1][2] - D-allulose, a low-calorie sugar alternative, is expected to see substantial market growth, with a projected global market size of $14.77 million in 2024 and a compound annual growth rate exceeding 14% from 2025 to 2034 [1][2] Company Developments - COFCO Group has established a comprehensive patent portfolio in the biosynthesis of D-allulose, with 17 patents covering production strains, enzyme preparations, separation processes, and overall production technology, of which 10 core patents have been authorized [2] - The company has developed a one-stop application solution and differentiated supply capabilities across various sectors, including beverages, baking, dairy, and confectionery, to accelerate the domestic application of D-allulose [2] Industry Impact - The introduction of D-allulose aligns with national public health initiatives, such as the "Weight Management Year," providing significant industrial support for the Healthy China strategy [2] - COFCO Group's commitment to innovation is reflected in its establishment of a dedicated technology innovation department and policies aimed at enhancing R&D investment and sharing benefits with researchers, fostering a collaborative ecosystem for the health food industry [3]

Investment Rating - The industry investment rating is "Outperform the Market" (maintained rating) [6] Core Viewpoints - The approval of D-Allulose as a new food ingredient in China marks its official application license, indicating significant market potential as a low-calorie sweetener with health benefits [1][2] - The global D-Allulose market is projected to grow at a CAGR of 33.26% from 2019 to 2023, with an expected market size of USD 545 million by 2030 [1] - Companies with relevant production capacity and technology are expected to benefit from the industry boom, with key recommendations including Bailong Chuangyuan, Baolingbao, and COFCO Technology [3] Summary by Sections Section 1: Industry Overview - D-Allulose is a natural low-calorie sweetener found in various plants, with a sweetness level of 70% compared to sucrose and only one-tenth of its calories [1] - The substance has been recognized for its health benefits, including vascular health and blood sugar regulation [1] Section 2: Production and Companies - COFCO Technology is the first and only company in China to produce D-Allulose using enzyme technology, having developed a proprietary enzyme for its production [2] - Bailong Chuangyuan has achieved over RMB 156 million in revenue from D-Allulose, with plans for significant capacity expansion in Thailand [3] - Baolingbao has been involved in D-Allulose research for nearly a decade and is expanding its production capacity to 30,000 tons by 2026 [3] Section 3: Investment Recommendations - The report recommends buying shares of Bailong Chuangyuan, Baolingbao, and COFCO Technology due to their established market positions and expansion plans [3][5]